The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

HBY 097

DRUG

Zidovudine

Trial Locations (6)

10016

New York Univ Med Ctr, New York

20007

Georgetown Univ Med Ctr, Washington D.C.

30912

Med College of Georgia, Augusta

77006

Houston Clinical Research Network, Houston

90033

Los Angeles County - USC Med Ctr, Los Angeles

943055107

Stanford Univ School of Medicine, Stanford

Sponsors
All Listed Sponsors
lead

Hoechst Marion Roussel

INDUSTRY

NCT00002357 - The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms | Biotech Hunter | Biotech Hunter